labour pain.
Conditions
Interventions
Intervention 1: Intervention group: intravenous remifentanil (ultra short acting potent opioid) with the loading dose of 0.25µg/kg and 0.025 µg/kg/min infusion from 0/5µg/cc solution for 30 minutes w
Treatment - Drugs
Placebo
Intervention group: intravenous remifentanil (ultra short acting potent opioid) with the loading dose of 0.25µg/kg and 0.025 µg/kg/min infusion from 0/5µg/cc solution for 30 minutes were used and in
Control group: Sodium chloride 0.9% is infused with the same rate for 30 minutes.During the each period of intravenous infusion , and inhaled entonox in each contraction
Sponsors
Vice-Chancellery for Research Isfahan University of Medical Sciences.
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: samples are taken from the ASA1 term parturients? cephalic presentation who are in the active phase of labor (dilation 4-8 cm) and natural delivery. Exclusion criteria: patients who do not have one of the interventional periods for any reasons (remifentanil and entonox)? have got serious complications that result cesarean section? NSAIDs and cigarette users.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Labour pain. Timepoint: before intervention and after each contraction. Method of measurement: VAS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation. Timepoint: Before and after intervention. Method of measurement: RAMSEY Score.;Nausea. Timepoint: Before and after intervention. Method of measurement: VAS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mojtaba Rahimi
Isfahan University of Medical Sciences
Outcome results
None listed